These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1632402)

  • 1. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group.
    Colfer HT; Ribner HS; Gradman A; Hughes CV; Kapoor A; Laidlaw JC
    Am J Cardiol; 1992 Aug; 70(3):354-8. PubMed ID: 1632402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term therapy with benazepril in patients with congestive heart failure: effects on clinical status and exercise tolerance.
    Ribner HS; Sagar KB; Glasser SP; Hsieh AM; Dills CV; Larkin S; DeSilva J; Whalen JJ
    J Clin Pharmacol; 1990 Dec; 30(12):1106-11. PubMed ID: 2273083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
    Insel J; Mirvis DM; Boland MJ; Cinquegrani MP; Shanes J; Rubin SA; Whalen JJ
    Clin Pharmacol Ther; 1989 Mar; 45(3):312-20. PubMed ID: 2537699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
    J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.
    Littler WA; Sheridan DJ
    Br Heart J; 1995 May; 73(5):428-33. PubMed ID: 7786657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic therapy for congestive heart failure with benazepril HCl, a new angiotensin converting enzyme inhibitor.
    Mirvis DM; Insel J; Boland MJ; Cinquegrani MP; Ghali JK; Rubin SA; Shanes J; DeSilva J; Whalen JJ
    Am J Med Sci; 1990 Dec; 300(6):354-60. PubMed ID: 2264573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
    Giles TD; Katz R; Sullivan JM; Wolfson P; Haugland M; Kirlin P; Powers E; Rich S; Hackshaw B; Chiaramida A
    J Am Coll Cardiol; 1989 May; 13(6):1240-7. PubMed ID: 2539403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy. The Lisinopril-Digoxin Study Group.
    Herlitz J
    Am J Cardiol; 1992 Oct; 70(10):84C-90C. PubMed ID: 1329479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of benazepril combined with valsartan on congestive heart failure].
    Ye JF; Liu DS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1441-2, 1447. PubMed ID: 16305977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
    Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
    Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition at rest and during exercise in congestive heart failure.
    Kelbaek H; Agner E; Wroblewski H; Vasehus Madsen P; Marving J
    Eur Heart J; 1993 May; 14(5):692-5. PubMed ID: 8508863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of benazepril plus hydrochlorothiazide versus benazepril alone in hypertensive patients unresponsive to benazepril monotherapy.
    Holwerda K; Hoogma RP; Oldenbroek C; Huige RC; Wester A; Rijnierse JM
    Clin Ther; 1994; 16(6):942-51. PubMed ID: 7697691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial.
    BENCH (BENazepril in Canine Heart disease) Study Group
    J Vet Cardiol; 1999 May; 1(1):7-18. PubMed ID: 19081317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure.
    Hamroff G; Katz SD; Mancini D; Blaufarb I; Bijou R; Patel R; Jondeau G; Olivari MT; Thomas S; Le Jemtel TH
    Circulation; 1999 Mar; 99(8):990-2. PubMed ID: 10051289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group.
    Erhardt L; MacLean A; Ilgenfritz J; Gelperin K; Blumenthal M
    Eur Heart J; 1995 Dec; 16(12):1892-9. PubMed ID: 8682023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and acceptability of perindopril in mild to moderate chronic congestive heart failure.
    Lechat P; Garnham SP; Desche P; Bounhoure JP
    Am Heart J; 1993 Sep; 126(3 Pt 2):798-806. PubMed ID: 8166887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
    Lewis BS; Rabinowitz B; Schlesinger Z; Caspi A; Markiewicz W; Rosenfeld T; Sclarovsky S; Ermer W
    Cardiology; 1999; 91(1):1-7. PubMed ID: 10393392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.